Compare Intuitive Surgical, Inc. (ISRG) vs NetEase Inc (NTES) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Intuitive Surgical, Inc. vs NetEase Inc — how do they compare? Intuitive Surgical, Inc. trades at $426.13 (market cap $146.76B), while NetEase Inc trades at $124.12 (market cap $76.09B). The key difference: Intuitive Surgical, Inc. is the larger of the two by market cap, and NetEase Inc pays a 2.45% dividend while Intuitive Surgical, Inc. pays none. Which is the better fit depends on your goals — on Pluang, investors hold Intuitive Surgical, Inc. for 84 Days and NetEase Inc for 74 Days on average.
| ISRG | NTES | |
|---|---|---|
Market Cap | $146.76B | $76.09B |
Volume | 2,529,814 | 486,447 |
Sector | Health | Technology |
52-Week High | $592.85 | $152.85 |
52-Week Low | $332.02 | $109.26 |
Typical Hold Time | 84 Days | 74 Days |
Enterprise Value | $141.54B | $51.81B |
Dividend Yield | — | 2.45% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Intuitive Surgical (ISRG) trades at $424.58, up 2.43% with strong bullish momentum. The stock shows robust fundamentals with revenue growing from $6.2B in 2022 to $10.1B in 2025 and net profit margins exceeding 28%. Recent earnings consistently beat expectations, with Q2 2026 EPS of $2.80 surpassing the $2.48 forecast. Technical indicators show bullish moving averages with support at $410 and resistance at $419. Analyst consensus remains strongly positive with 70% buy ratings and a $480.78 price target.
ISRG maintains a dominant position in robotic surgery with expanding international growth offsetting China headwinds. The primary investment opportunity lies in continued procedure growth and da Vinci 5 adoption, though risks include competitive pressures and affordability concerns. With strong cash flow generation and institutional support, the stock presents upside potential despite premium valuations.
NTES trades at $124.20, up 2.98% today, with a neutral technical signal and mixed earnings history. The company reported Q2 2026 revenue growth of 8% year-over-year to $4.4 billion, though EPS missed expectations. Strong fundamentals include a 27.88% net income margin and robust cash flow from operations of $50.74 billion in 2025. Recent news highlights focus on gaming performance and AI investments.
Outlook remains positive with an 81.82% analyst buy rating and a $168.00 consensus price target, implying significant upside. Risks include earnings volatility and competitive pressures in the gaming sector. The stock presents a value opportunity given its reasonable P/E of 15.92 and strong balance sheet with $137.58 billion in cash.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Intuitive Surgical, Inc.
Intuitive Surgical develops, produces, and markets a robotic system for assisting minimally invasive surgery. It also provides the instrumentation, disposable accessories, and warranty services for the system. The company has placed nearly 7,000 da Vinci systems in hospitals worldwide, with more than 4,000 installations in the United States and a growing number in emerging markets.
Read more on ISRG →About NetEase Inc
NetEase, which started on an internet portal service in 1997, is a leading online services provider in China. Its key services include online/mobile games, cloud music, media, advertising, email, live streaming, online education, and e-commerce. The company develops and operates some of the China's most popular PC client and mobile games, and it partners with global leading game developers, such as Blizzard Entertainment and Mojang (a Microsoft subsidiary).
Read more on NTES →
